Biogen revenue by product
WebBiogen's marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of multiple ... for the treatment of severe … Web2024 Annual Report. 2024 Annual Report. 2024 Annual Report. 2024 Annual Report. 2024 Annual Report. 2016 Annual Report. 2015 Annual Report.
Biogen revenue by product
Did you know?
WebJan 30, 2024 · Biogen also announced its full year 2024 financial guidance. This financial guidance consists of the following components: • Revenue is expected to be … WebFeb 20, 2024 · Biogen's product revenue 2016-2024, by therapeutic area. Biogen's product revenue from 2016 to 2024, by therapeutic area (in million U.S. dollars) …
WebFeb 15, 2024 · Full Year 2024 Financial Guidance. • Expect mid-single digit revenue decline versus 2024 and Non-GAAP EPS of $15.00 to $16.00. Commenting on Biogen Inc. (Nasdaq: BIIB) results, President and Chief Executive Officer Christopher A. Viehbacher said: “Strategically, we are working to put Biogen on a sustainable growth trajectory as … WebBiogen Investor Relations
WebFeb 3, 2024 · Biogen expects full year 2024 revenue to be between $9.7 billion and $10.0 billion. This financial guidance assumes minimal ADUHELM revenue in 2024. This … WebBiogen's product revenue 2016-2024, by therapeutic area; Biogen's top products based on revenue 2016-2024; Biogen's revenues by type and region 2024; The most …
WebApr 9, 2024 · Biogen ( NASDAQ:BIIB - Get Rating) last released its earnings results on Wednesday, February 15th. The biotechnology company reported $4.05 EPS for the quarter, topping analysts' consensus estimates of $3.48 by $0.57. The business had revenue of $2.54 billion for the quarter, compared to the consensus estimate of $2.44 …
WebMar 27, 2024 · Biogen revenue is $10.2B. Among it's competitors, the company with the highest revenue is Pfizer, $100.3B . The company with the lowest revenue is Genentech, $166.9M. ... In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took … raw pigeon meal romeWebApr 14, 2024 · Biogen Price Performance. Shares of NASDAQ BIIB opened at $289.70 on Friday. Biogen Inc. has a fifty-two week low of $187.16 and a fifty-two week high of $311.88. The stock has a market cap of $41 ... raw pine furniture ukWebOct 15, 2024 · Biogen earnings report Biogen reported revenue of $2.589 billion for the second quarter of 2024, which was down 6% year over year. The company also had earnings per share (EPS) of $7.24, up... raw pink shoesWebOct 20, 2024 · As of September 30, 2024, Biogen had $7,271 million in total debt. Cash, cash equivalents, and marketable securities totaled $3,923 million. This resulted in net … simple ira and roth iraWebFeb 16, 2024 · Biogen Inc. is a Massachusetts-based biotech company specializing in drugs for neurological disorders, autoimmune disorders and cancer. In 2024, one of the company's top products, Spinraza,... raw pine nuts dangersraw pine flooringWebJul 23, 2024 · Biogen wins patent victory against Mylan for Tecfidera, which accounted for 30% of Biogen's revenue in 2024 (Kuchler 2024). 02/11/2024 Aducanumab's efficacy in treating Alzheimer's is revised ... raw picture format